Screening of Some Triterpenoids Isolated from Terminalia arjuna as Inhibitors of Angiotensin Converting Enzyme to Prevent Cardiovascular Diseases

Authors

  • Manabendra Dutta Choudhury Bioinformatics Centre, Assam University, Silchar, Assam, India
  • Monjur Ahmed Laskar Bioinformatics Centre, Assam University, Silchar, Assam, India

Abstract

Natural products have been shown to present interesting biological and pharmacological activities and are used as chemotherapeutic agents. Plants have historically been used in treating cardiovascular diseases (CVD) and are recognized for their ability to produce secondary metabolites. Secondary metabolites obtained from different plants have been the starting material for designing different drugs. Many useful phytoconstituents have been isolated from Terminalia arjuna. Tannins and flavonoids are responsible for its anticancer properties and triterpenoids are mainly responsible for cardiovascular properties. In the present study, we have analyzed the inhibitory potential of triterpenoids, on the Angiotensin Converting Enzyme (ACE) - the enzyme responsible for various cardiovascular diseases. The study revealed that some of the triterpenoids have high ACE inhibiting potential and also significant IC 50 values as compared to other known ACE inhibitors.

 

Keywords: Secondary metabolites, phytoconstituents, triterpenoids, ACE, cardioprotective, IC50

Downloads

Published

2019-03-19

Issue

Vol. 1 No. 3 (2014)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.